Stifel analyst Daniel Arias lowered the firm’s price target on Illumina (ILMN) to $135 from $160 and keeps a Buy rating on the shares. Illumina posted a “nice” Q1 beat and then reduced the FY25 guidance, as expected, the analyst tells investors. The cut to the top-line “was maybe a point or so deeper than we thought it might be,” but the EPS outlook is better than the firm anticipated thanks to strong mitigation activities, the analyst added.

Protect Your Portfolio Against Market Uncertainty

Discover companies with rock-solid fundamentals in  TipRanks' Smart Value Newsletter. Receive undervalued stocks, resilient to market uncertainty,  delivered straight to your inbox.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on ILMN:

Disclaimer & DisclosureReport an Issue

Illumina price target raised to $89 from $86 at TD Cowen Illumina price target lowered to $85 from $120 at JPMorgan Illumina price target lowered to $114 from $122 at Guggenheim Illumina’s Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges Illumina Reports Q1 2025 Financial Results Amid Challenges

View Comments